Close
ACHEMA MIDDLE EAST 2026

Machine Conditioning Monitoring – Making Inroads In Pharma

The pharma industry relies extensively on the trust when it comes to consumers as well as communities. As a result, it remains a very...

Predictive Maintenance – AI Aspect In Pharma Manufacturing

Pharmaceutical manufacturing happens to be a highly challenging and precise process that is crucial and has a prominent impact across various industries. One of...

Industry 5.0 Has Plenty To Offer To Pharma Manufacturing

In the last dozen years, Industry 4.0 has brought about a significant transformation when it comes to manufacturing technology. It has enabled machines to...

Improving Approach of UK Through Future Clinical Trials Bill

The Policy Exchange has come up with a report that highlights the potential benefits of The Future Clinical Trials Bill when it comes to improving...

Pharma Packaging Market In Europe To Hit $35bn Come 2028

As per a report furnished by Arizton, the pharma packaging and labelling market across Europe is expected to reach $35.78 billion by 2028. This particular segment in Europe,...

Prominent Pharma Antitrust Lawsuits Over The Last Decade

Although one must have heard of tech giants such as Microsoft, Apple, as well as Meta getting caught up in certain antitrust scandals, big...

Xtandi Clones By Sun Pharma – Astellas-Pfizer Settle Case

As per findings pertaining to court filings, Astellas Pharma Inc. and Pfizer Inc. have gone on to reach a settlement in their lawsuit against...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...